Literature DB >> 28831911

Nanoparticle-Based Drugs: A Potential Armamentarium of Effective Anti-Cancer Therapies.

Khurshid Ahmad1, Gulam Rabbani1, Mohammad Hassan Baig1, Jeong Ho Lim1, Mohammad Ehtisham Khan2, Eun Ju Lee1, Ghulam Md Ashraf3, Inho Choi1.   

Abstract

BACKGROUND: Cancer is a foremost cause of mortality worldwide. Available treatments are non-specific and cannot cross biological barriers, which have restricted their usages. Furthermore, the side effects of existing treatments have promoted the exploration of nanotechnological approaches to achieve site-specific drug delivery. The diminutive sizes of nanoparticles, and hence, their large surface to volume ratios, means they are inherently more efficient at delivering drugs to specific tumor sites. This review highlights different approaches to cancer therapy, and the importance of nanoparticles in cancer therapy. Applications and limitations of different types of nanomedicines used for cancer imaging and treatment are discussed.
METHODS: We undertook extensive literature search of bibliographic databases (e.g. PubMed, Google Scholar, Medline, Web of Science etc.) using different keywords and combination of keywords to retrieve the relevant information.
RESULTS: This review provides overview of cancer and need for nanoparticle-based therapies for their treatment, and deliberates the different types of nanomaterials used as nanomedicines for cancer imaging and treatment in addition to their applications and limitations. Furthermore, applications of nanoparticles in modern cancer therapies and research strategies have been explored to overcome cancer.
CONCLUSION: Nanotechnology has provided a lot of novel therapeutics for the diagnosis and treatment of different cancers over the last 2-3 decades. However, there are few limitations of nanotechnological based anti-cancer therapies. Nanotechnology is enabling novel, specialized treatments for cancer; this will be a high-impact area of nanomedicine yielding more medical advancements with the next 10 years. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Cancer; drug delivery; nanodevices; nanomedicines; nanoparticles; therapeutics.

Mesh:

Substances:

Year:  2018        PMID: 28831911     DOI: 10.2174/1389200218666170823115647

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  4 in total

Review 1.  Nanodelivery of phytobioactive compounds for treating aging-associated disorders.

Authors:  Oleh Lushchak; Olha Strilbytska; Alexander Koliada; Alina Zayachkivska; Nadia Burdyliuk; Ihor Yurkevych; Kenneth B Storey; Alexander Vaiserman
Journal:  Geroscience       Date:  2019-11-04       Impact factor: 7.713

2.  Nuclear VEGFR-2 Expression of Hepatocytes Is Involved in Hepatocyte Proliferation and Liver Regeneration During Chronic Liver Injury.

Authors:  A-Rang Lee; Su-Min Baek; Seoung-Woo Lee; Tae-Un Kim; Jee Eun Han; Seulgi Bae; Sang-Joon Park; Tae-Hwan Kim; Kyu-Shik Jeong; Seong-Kyoon Choi; Jin-Kyu Park
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

3.  Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel.

Authors:  Eglal I Amer; Iman Fathy Abou-El-Naga; Laila M Boulos; Heba S Ramadan; Salwa S Younis
Journal:  Biomedica       Date:  2022-03-01       Impact factor: 1.173

4.  Investigation of the Immune Modulatory Potential of Zinc Oxide Nanoparticles in Human Lymphocytes.

Authors:  Helena Moratin; Pascal Ickrath; Agmal Scherzad; Till Jasper Meyer; Sebastian Naczenski; Rudolf Hagen; Stephan Hackenberg
Journal:  Nanomaterials (Basel)       Date:  2021-03-03       Impact factor: 5.076

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.